+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Surgical Site Infection Control Market by Product, Type, Phase, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5675085
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Surgical Site Infection Control Market grew from USD 5.29 billion in 2023 to USD 5.62 billion in 2024. It is expected to continue growing at a CAGR of 6.34%, reaching USD 8.14 billion by 2030.

The scope of the surgical site infection (SSI) control market encompasses a range of measures, products, and protocols aimed at preventing infections during and after surgical procedures. This includes infection prevention products like antiseptics, sterile drapes, surgical gloves, and innovative wound dressings. With SSIs being a significant concern due to their negative impact on patient recovery and healthcare costs, the necessity of effective infection control is undisputed. The primary application spans hospitals, outpatient facilities, and specialized clinics, with end users being healthcare providers and patients themselves. Key factors driving market growth include the rise in surgical procedures, increased awareness about hospital-acquired infections, and technological advancements in medical equipment and materials. The COVID-19 pandemic further accentuated the demand for effective infection control solutions, providing potential opportunities in the development of novel antimicrobial technologies and personalized infection control protocols. Telemedicine and digital health platforms represent additional areas ripe for innovation, influencing patient education and compliance with infection control measures. However, market growth is hampered by high costs of advanced products, budget constraints in developing regions, and regulatory challenges concerning product approval and standard compliance. Opportunities also exist in enhancing sterilization techniques and integrating artificial intelligence into infection surveillance systems, offering predictive insights and real-time tracking of infection control measures. Companies can leverage partnerships and collaborations with research institutions to stay at the forefront of innovation. The market is characterized by intense competition and a fragmented landscape with numerous players, necessitating strategic positioning and continual adaptation to regulatory changes. The best areas for research include the development of cost-effective single-use products and sustainable practices, underscoring the importance of ongoing investment in R&D to drive business growth and maintain competitive advantage.

Understanding Market Dynamics in the Surgical Site Infection Control Market

The Surgical Site Infection Control Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rise in number of hospital-acquired infections
    • Prevalence of chronic disease and increasing surgery options
    • Government support for advancing hospital infrastructure
  • Market Restraints
    • Difficulty in identifying the surgical site infection
  • Market Opportunities
    • Technological advancements in surgical infection control
    • Biofilms for eradicating surgical site infections
  • Market Challenges
    • Reluctance for implementation of standard norms for surgical procedures

Exploring Porter’s Five Forces for the Surgical Site Infection Control Market

Porter’s Five Forces framework further strengthens the insights of the Surgical Site Infection Control Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Surgical Site Infection Control Market

External macro-environmental factors deeply influence the performance of the Surgical Site Infection Control Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Surgical Site Infection Control Market

The Surgical Site Infection Control Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Surgical Site Infection Control Market

The Surgical Site Infection Control Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Surgical Site Infection Control Market

The Surgical Site Infection Control Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Surgical Site Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Ansell Ltd., B. Braun Melsungen AG, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Covalon Technologies Ltd., Europe BV, Getinge Group, Johnson & Johnson Services, Inc., Kimberly-Clark Corporation, Medtronic PLC, Mölnlycke Health Care AB, Paul Hartmann AG, Prescient Surgical, Inc., Steris Corporation, Stryker Corporation, and Winner Medical Group Inc..

Market Segmentation & Coverage

This research report categorizes the Surgical Site Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Antibiotic Prophylaxis Products
    • Antiseptics & Disinfectants
    • Clippers
    • Surgical Drapes
    • Wound Care Dressings
    • Wound Irrigation Products
  • Type
    • Deep Incisional Infection
    • Space Infection
    • Superficial Incisional Infection
  • Phase
    • Intraoperative Phase
    • Postoperative Phase
    • Preoperative Phase
  • End-user
    • Ambulatory Surgery Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in number of hospital-acquired infections
5.1.1.2. Prevalence of chronic disease and increasing surgery options
5.1.1.3. Government support for advancing hospital infrastructure
5.1.2. Restraints
5.1.2.1. Difficulty in identifying the surgical site infection
5.1.3. Opportunities
5.1.3.1. Technological advancements in surgical infection control
5.1.3.2. Biofilms for eradicating surgical site infections
5.1.4. Challenges
5.1.4.1. Reluctance for implementation of standard norms for surgical procedures
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Surgical Site Infection Control Market, by Product
6.1. Introduction
6.2. Antibiotic Prophylaxis Products
6.3. Antiseptics & Disinfectants
6.4. Clippers
6.5. Surgical Drapes
6.6. Wound Care Dressings
6.7. Wound Irrigation Products
7. Surgical Site Infection Control Market, by Type
7.1. Introduction
7.2. Deep Incisional Infection
7.3. Space Infection
7.4. Superficial Incisional Infection
8. Surgical Site Infection Control Market, by Phase
8.1. Introduction
8.2. Intraoperative Phase
8.3. Postoperative Phase
8.4. Preoperative Phase
9. Surgical Site Infection Control Market, by End-user
9.1. Introduction
9.2. Ambulatory Surgery Centers
9.3. Clinics
9.4. Hospitals
10. Americas Surgical Site Infection Control Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Surgical Site Infection Control Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Surgical Site Infection Control Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. SURGICAL SITE INFECTION CONTROL MARKET RESEARCH PROCESS
FIGURE 2. SURGICAL SITE INFECTION CONTROL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. SURGICAL SITE INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. SURGICAL SITE INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SURGICAL SITE INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SURGICAL SITE INFECTION CONTROL MARKET DYNAMICS
TABLE 7. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY ANTIBIOTIC PROPHYLAXIS PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY ANTISEPTICS & DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY CLIPPERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY SURGICAL DRAPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY WOUND CARE DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY WOUND IRRIGATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY DEEP INCISIONAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY SPACE INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY SUPERFICIAL INCISIONAL INFECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY INTRAOPERATIVE PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY POSTOPERATIVE PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PREOPERATIVE PHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. CANADA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. CANADA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. CANADA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. CANADA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. MEXICO SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. CHINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. CHINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. CHINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 64. CHINA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. INDIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 68. INDIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. JAPAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 74. JAPAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. JAPAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. THAILAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. THAILAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. THAILAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 100. THAILAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 111. DENMARK SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. EGYPT SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. EGYPT SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. EGYPT SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 117. EGYPT SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FINLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. FINLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FINLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. FRANCE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. FRANCE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. GERMANY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. GERMANY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. ITALY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. ITALY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 137. ITALY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. NORWAY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 147. NORWAY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. NORWAY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 149. NORWAY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. POLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. POLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. POLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 153. POLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. QATAR SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. QATAR SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 157. QATAR SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. SPAIN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 173. SPAIN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. TURKEY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 183. TURKEY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. TURKEY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 185. TURKEY SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SURGICAL SITE INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. SURGICAL SITE INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Surgical Site Infection Control Market, which are profiled in this report, include:
  • 3M Company
  • Ansell Ltd.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Belimed AG
  • bioMerieux SA
  • Covalon Technologies Ltd.
  • Europe BV
  • Getinge Group
  • Johnson & Johnson Services, Inc.
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Mölnlycke Health Care AB
  • Paul Hartmann AG
  • Prescient Surgical, Inc.
  • Steris Corporation
  • Stryker Corporation
  • Winner Medical Group Inc.

Methodology

Loading
LOADING...

Table Information